Company Tekla Life Sciences Investors Nyse
Equities
US4040531000
Closed End Funds
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Investment and Related Activities
100.0
%
| 32 | 100.0 % | 39 | 100.0 % | +23.60% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 32 | 100.0 % | 39 | 100.0 % | +23.60% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dan Omstead
PSD | President | 71 | 31/12/00 |
Jason Akus
CTO | Chief Tech/Sci/R&D Officer | - | - |
Laura Woodward
CMP | Compliance Officer | 56 | 31/12/08 |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 31/12/06 | |
Dan Omstead
PSD | President | 71 | 31/12/00 |
Jeffrey Bailey
BRD | Director/Board Member | 62 | 31/12/19 |
William Watson
BRD | Director/Board Member | 73 | 16/03/22 |
Thomas Kent
BRD | Director/Board Member | 71 | 18/12/17 |
Kathleen Goetz
BRD | Director/Board Member | - | 31/12/20 |
- | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 27,350,517 | 27,348,517 ( 99.99 %) | 0 | 99.99 % |
Company contact information
abrdn Life Sciences Investors
1900 Market Street Suite 200
19103, Philadelphia
+215 405 5700
http://www.teklacap.com/hql.html![address Tekla Life Sciences Investors](https://cdn.zonebourse.com/static/address/409014.png)
1st Jan change | Capi. | |
---|---|---|
+5.34% | 12.97B | |
+14.22% | 9.75B | |
+0.95% | 5.65B | |
+31.56% | 5.23B | |
+6.24% | 5.22B | |
-4.99% | 5.04B | |
+23.73% | 4.73B | |
+2.95% | 3.91B | |
-2.97% | 3.81B |
- Stock Market
- Equities
- HQL Stock
- Stock
- Company Tekla Life Sciences Investors